The announcement comes after the FDA became aware of more than 40 cases of "DRESS syndrome" linked to the seizure medications levetiracetam and clobazam.
The announcement comes after the FDA became aware of more than 40 cases of "DRESS syndrome" linked to the seizure medications levetiracetam and clobazam.